{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-020657","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.324907+00:00","generated_at":"2026-05-15T00:40:44.841467+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NexGel appoints Ian Blackman as CFO; Adam Drapczuk resigns as interim CFO","bullets":["Ian Blackman appointed CFO effective April 27, 2026; CPA with over 30 years of finance leadership experience.","Base salary of $250,000; cash bonus tied to EBITDA tiers: 10% at $4M, 30% at $6M, 50% at $8M.","Received initial option grant for 160,000 shares, 5-year term, vesting over 4 years with acceleration upon change in control.","Press release links appointment to advancing Celularity acquisition: definitive agreement to license/acquire regenerative biomaterial products from Celularity (NASDAQ: CELU).","Adam Drapczuk resigned as interim CFO with no disagreement; will continue providing consulting services."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-020657","json":"https://secwatch.observer/filing/0001493152-26-020657.json","markdown":"https://secwatch.observer/filing/0001493152-26-020657.md","text":"https://secwatch.observer/filing/0001493152-26-020657.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:40:44.841467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2e2d1a9d53","claim":"Adam Drapczuk resigned as Chief Financial Officer at NEXGEL, INC..","evidence_excerpt":"Mr. Blackman succeeds Mr. Drapczuk as the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"93d184ce56","claim":"Ian Blackman was appointed as Chief Financial Officer at NEXGEL, INC..","evidence_excerpt":"the Board of Directors of the Company (the “ Board ”) appointed Ian Blackman, age 58, as Chief Financial Officer of NexGel, Inc. (the “ Company ”), effective April 27, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}